Patients who return to care after tracking remain at high risk of attrition: experience from a large HIV clinic,Uganda

Abstract

We determined the retention rate of patients infected with HIV who resumed care after being tracked at the Infectious Diseases Clinic (IDC) in Kampala, Uganda. Between April 2011 and September 2013, patients who missed their clinic appointment for 8–90 days were tracked, and those who returned to the clinic within 120 days were followed up. The proportion of patients retained among tracked patients, and those who resumed care before tracking started was compared. At 18 months of follow up, 33 (39%) of the tracked patients and 72 (61%) of those who had resumed care before tracking started were retained in care. The most important cause of attrition among the traceable was self-transfer to another clinic (38 [73%] patients), whereas among those who resumed care before tracking was loss to follow up (LTFU) (32 [71%] patients). Tracked patients who resume care following a missed appointment are at high risk of attrition. To increase retention, antiretroviral therapy clinics need to adopt a chronic care model which takes into consideration patients’ changing needs and their preference for self-management.

Keywords

HIV AIDS treatment tracking antiretroviral therapy missed appointment resuming care patients’ retention risk of attrition loss to follow up resource-limited setting Uganda

Get full access to this article

View all access options for this article.

References

Alamo

Colebunders

Ouma

. Return to normal life after AIDS as a reason for lost to follow up in a community-based antiretroviral treatment program. J Acquir Immune Defic Syndr 2012; 60(2): 36–45.

Geng

Bangsberg

Musinguzi

. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda. J Acquir Immune Defic Syndr 2010; 53(3): 405–411.

Nakiwogga-Muwanga A, Alamo TS, Musaazi J, et al. Inadequate patient monitoring in advanced stages of disease and lack of supportive counseling increase patient attrition on antiretroviral treatment from a large urban HIV clinic in Uganda. JIAPAC. Epub ahead of print 30 September 2013. DOI: 10.1177/2325957413501719.

McMahon

Elliott

Hong

. Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review. PLoS One 2013; 8(2): e56047–e56047.

Palella

Jr Delaney

Moorman

. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853–860.

Parienti

Massari

Descamps

. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis 2004; 38: 1311–1316.

Oyugi

Byakika-Tusiime

Ragland

. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007; 21: 965–971.

Kamya

Mayanja-Kizza

Kambugu

. Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2007; 46(2): 187–193.

Nakiwogga-Muwanga A, Katabira E, Kiragga A, et al. Factors before enrolment are associated with being removed from a Pharmacy-only Refill Program at a large urban HIV/AIDS clinic, Uganda. Int J STD AIDS. Epub ahead of print 19 July 2013.

10.

Brinkhof

MWG

Pujades-Rodriguez

Egger

. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 2009; 4(6): e5790–e5790.

11.

Hogg

Yip

Chan

. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple drug therapy. JAMA 2001; 286(20): 2568–2577.

12.

Rosen

Fox

Gill

. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 2007; 4(10): e298–e298.

13.

Braitstein

Brinkhof

Dabis

. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367(9513): 817–824.

14.

Wouters

Van Damme

Van Rensburg

. Impact of community-based support services on antiretroviral treatment programme delivery and outcomes in resource-limited countries: a synthetic review. BMC Health Serv Res 2012; 12: 194–194.

15.

Muwanga A, Easterbrook P, Schaefer P, et al. Losses to follow-up in a large ART Program in Uganda. In: 15th conference on retroviruses and opportunistic infections, Boston, USA, 3–6 February 2008, Abstract number 840.

16.

Yiannoutsos

Frangakis

. Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS One 2008; 3(12): e3843–e3843.

17.

Nakiwogga-Muwanga A, Katabira E, Sempa J, et al. A pharmacy-only refill program at a large HIV clinic in Uganda: experience and satisfaction of patients. J Int Assoc Provid AIDS Care. Epub ahead of print 6 June 2013.